Experimental cancer treatments are more beneficial than previously thought.

In a recent study, the largest and most comprehensive to date, approximately 11%—and in some cases, 27%-of patients in Phase 1 cancer trials responded positively. Previous reviews showed that only 4% to 6% benefited.

Want to Keep Reading?

Continue reading with a Health Confidential membership.

Sign up now Already have an account? Sign in